David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
CALL
State Street
STT
$53.2B
| $1.26M | ﹤0.01% |
19,100
-45,000
| -70% | -$3.12M |
|
2427
PUT
Invesco
IVZ
$14.6B
| $1.25M | ﹤0.01% |
64,800
-146,800
| -69% | -$2.74M |
|
|
SNV
2428
DELISTED
Synovus
SNV
| $1.25M | ﹤0.01% |
36,345
-292,545
| -89% | -$10.7M |
|
2429
Encore Capital Group
ECPG
$2.12B
| $1.25M | ﹤0.01% |
45,814
+18,307
| +67% | +$547K |
|
2430
CALL
Thor Industries
THO
$4.05B
| $1.25M | ﹤0.01% |
20,000
+2,500
| +14% | +$158K |
|
2431
PUT
Targa Resources
TRGP
$63B
| $1.25M | ﹤0.01% |
+30,000
| New | +$1.26M |
|
|
DF
2432
DELISTED
Dean Foods Company
DF
| $1.24M | ﹤0.01% |
410,475
-15,616
| -4% | -$62.8K |
|
2433
Community Bank
CBU
$3.32B
| $1.24M | ﹤0.01% |
20,801
-4,916
| -19% | -$303K |
|
2434
News Corp Class B
NWS
$18.9B
| $1.24M | ﹤0.01% |
99,367
-9,082
| -8% | -$116K |
|
|
PNNT
2435
Pennant Park Investment Corp
PNNT
$246M
| $1.24M | ﹤0.01% |
179,221
+108,657
| +154% | +$765K |
|
|
BLD
2436
PUT
DELISTED
TopBuild
BLD
| $1.24M | ﹤0.01% |
19,100
-5,800
| -23% | -$326K |
|
|
HOUS
2437
DELISTED
Anywhere Real Estate
HOUS
| $1.24M | ﹤0.01% |
108,524
-531,726
| -83% | -$8.2M |
|
2438
PUT
Franco-Nevada
FNV
$51.6B
| $1.23M | ﹤0.01% |
16,400
-2,600
| -14% | -$193K |
|
2439
Alerian MLP ETF
AMLP
$13.4B
| $1.23M | ﹤0.01% |
+24,508
| New | +$1.2M |
|
2440
CALL
Toyota
TM
$227B
| $1.23M | ﹤0.01% |
10,400
+5,400
| +108% | +$653K |
|
2441
Bunge Global
BG
$21.8B
| $1.23M | ﹤0.01% |
23,077
+17,748
| +333% | +$942K |
|
2442
PUT
Valmont Industries
VMI
$9.21B
| $1.22M | ﹤0.01% |
9,400
-12,900
| -58% | -$1.66M |
|
2443
CALL
EnerSys
ENS
$6.96B
| $1.22M | ﹤0.01% |
+18,700
| New | +$1.41M |
|
2444
PUT
Darden Restaurants
DRI
$24.8B
| $1.22M | ﹤0.01% |
10,000
-42,100
| -81% | -$4.62M |
|
2445
CALL
Adient
ADNT
$1.46B
| $1.21M | ﹤0.01% |
93,700
+67,300
| +255% | +$1.18M |
|
|
FL
2446
PUT
DELISTED
Foot Locker
FL
| $1.21M | ﹤0.01% |
20,000
-15,900
| -44% | -$926K |
|
2447
PUT
BlackBerry
BB
$4.57B
| $1.21M | ﹤0.01% |
120,000
| – | – |
|
2448
NexGen Energy
NXE
$7.42B
| $1.21M | ﹤0.01% |
748,200
+294,900
| +65% | +$512K |
|
2449
New Mountain Finance
NMFC
$715M
| $1.21M | ﹤0.01% |
89,099
+71,967
| +420% | +$980K |
|
|
ANAT
2450
CALL
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.21M | ﹤0.01% |
+10,000
| New | +$1.37M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.